List view / Grid view
A clinical trial has shown that nOPV2 has the potential to overcome outbreaks caused by a mutated polio strain linked to the Sabin vaccine.
Behind every technological advance there is often a leadership story just as interesting. In this article, Ben Woollard highlights key leadership behaviours that have been fundamental in biological innovation and suggests how businesses can implement these attributes to strive forward in a new era of biologics.
Dr Saurabh Kumar Banerjee outlines the impact of COVID-19 on immunisation programmes in India and how organisations can hope to mitigate the consequences of missed vaccine doses.
A polio vaccine designed to be incapable of evolving the ability to cause disease in humans has shown promise in a Phase I clinical trial.
University of Leeds researchers have discovered a method to produce polio vaccines made from virus-like particles, which is being trialled on a manufacturing platform.
10 May 2016 | By Victoria White, Digital Content Producer
Takeda has received $38 million grant from the Bill & Melinda Gates Foundation to support global polio eradication in developing countries...
13 January 2016 | By Victoria White
To sustain progress made in eradicating polio to date, and tto protect all children from the disease, experts say $1.5 billion is urgently needed...
1 December 2015 | By Victoria White
These first vaccine doses will be available to implement one dose of IPV for all infants in the country...
16 June 2015 | By Victoria White
Rotary has granted $40.3 million to support immunisation activities and research carried out by the Global Polio Eradication Initiative...